Pharmaceutical Care
Management Association
325 7th Street, NW
Washington, DC 20004
Main: 202.756.5700
©2022 PCMA. All Rights Reserved.
PBM Tools PBM Tools Will Save Health Plan Sponsors and Consumers More than $1 Trillion on Prescription Drug Costs As prescription drug spending continues to increase, research shows PBMs’ cost savings and patient care management tools should reduce prescription drug
COVID-19: How PBMs Are Helping Patients and Health Plans Principles on Patient Access to Prescription Drugs PBMs are committed to helping the patients with convenient, reliable access to their needed prescription drugs. As patients evaluate their prescription drug needs, we
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released a new report, “Drug Manufacturer Strategies for Keeping Drug Costs High,” on pharmaceutical industry pricing tactics that increase prescription drug costs for patients. The report, conducted by the research firm Visante,
(Washington, D.C.) — As the House Committee on Oversight and Reform continues its investigation into drug manufacturers’ pricing strategies, the Pharmaceutical Care Management Association (PCMA) is releasing new data on the impact of blocking competition for top-selling medications. Brand-name drug manufacturers
Health Equity Working together for a more equitable health care system. For America’s PBMs, our mission is simple: increase affordable access to prescription drugs for everyone. We believe care should be patient-focused, equitable, and affordable. We commit to industry action
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health and Human Services Office of Inspector General’s proposed rule on prescription drug rebates in Medicare: “While we are reviewing the proposed
Upcoming Events Events 10 Nov 10 Nov – 11 Nov Test 2021-11-10 01:00 AM – 2021-11-11 03:00 AM Online Event PCMA Spring Webinar Series 2020 The live webinar series is designed to highlight drug supply chain executives’ thoughts and strategies
(Washington, D.C.) —Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on today’s action in the House Judiciary Committee on legislation aimed at increasing competition in the prescription drug marketplace. “We applaud the House Judiciary
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Biden Administration’s announcement to curb drug manufacturer patent abuses. “We applaud the Biden Administration for taking real action to reduce prescription
©2022 PCMA. All Rights Reserved.